Lopinavir/ritonavir

Lopinavir/ritonavir Reactions 1680, p210 - 2 Dec 2017 Elevated lipid levels following off-label use: case report In a retrospective study consisting of 40 patients (aged 1-17 years), a patient [age and sex not stated] was described who developed elevated lipid levels after receiving off-label dose of lopinavir/ritonavir [route and dosage not stated]. The patient, who had a history of HIV-1 infection, was receiving lopinavir/ritonavir twice a day. Later, the patient was switched to lopinavir/ritonavir once a day. Subsequently, the patient presented with constantly elevated lipid levels. The highest measured level of triglyceride was 7.8 mmol/L and cholesterol was 9.4 mmol/L. Lopinavir/ritonavir was discontinued [duration of treatment to reaction onset and outcome not stated]. Author comment: "One child stopped treatment because of persistent elevated lipid levels, with highest measured cholesterol of 9.4 mmol/L and triglycerides of 7.8 mmol/L." "Intolerability is mostly reported in treatment-naive children. In our study, lipid profiles remained stable and within the normal range in most children." "[Lopinavir/ritonavir] is approved to be used BID only in children, and once-daily use is therefore considered off-label." Gondrie IPE, et al. Sustained Viral Suppression in HIV-infected Children on Once- daily Lopinavir/Ritonavir in Clinical Practice. Pediatric Infectious Disease Journal 36: 976-980, No. 10, Oct 2017. Available from: URL: http://doi.org/10.1097/ INF.0000000000001627 - Netherlands 803286040 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Lopinavir/ritonavir

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/lopinavir-ritonavir-ylafKCzOZa
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39141-5
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p210 - 2 Dec 2017 Elevated lipid levels following off-label use: case report In a retrospective study consisting of 40 patients (aged 1-17 years), a patient [age and sex not stated] was described who developed elevated lipid levels after receiving off-label dose of lopinavir/ritonavir [route and dosage not stated]. The patient, who had a history of HIV-1 infection, was receiving lopinavir/ritonavir twice a day. Later, the patient was switched to lopinavir/ritonavir once a day. Subsequently, the patient presented with constantly elevated lipid levels. The highest measured level of triglyceride was 7.8 mmol/L and cholesterol was 9.4 mmol/L. Lopinavir/ritonavir was discontinued [duration of treatment to reaction onset and outcome not stated]. Author comment: "One child stopped treatment because of persistent elevated lipid levels, with highest measured cholesterol of 9.4 mmol/L and triglycerides of 7.8 mmol/L." "Intolerability is mostly reported in treatment-naive children. In our study, lipid profiles remained stable and within the normal range in most children." "[Lopinavir/ritonavir] is approved to be used BID only in children, and once-daily use is therefore considered off-label." Gondrie IPE, et al. Sustained Viral Suppression in HIV-infected Children on Once- daily Lopinavir/Ritonavir in Clinical Practice. Pediatric Infectious Disease Journal 36: 976-980, No. 10, Oct 2017. Available from: URL: http://doi.org/10.1097/ INF.0000000000001627 - Netherlands 803286040 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off